##  [CAR-T Healthcare Professionals](/research-and-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals "CAR-T Healthcare Professionals") 

  ![Image of two healthcare professionals interacting](/sites/novartis_com/files/styles/crop_freeform/public/2021-09/healthcare-professionals.jpg.webp?itok=msynXbQs "Image of two healthcare professionals interacting")

 



 



## The Science

This page explains the science of CAR-T cell therapy, including its mechanism of action and the structure of 4-1BB CAR-T cells, as well as efficacy, safety, and patient identification.

[Learn More](/research-and-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals/science-car-t-cell-therapy "The Science of CAR-T Cell Therapy")



 



## The Process

This page explains the manufacturing process of CAR-T cell therapy, including details such as leukapheresis, cryopreservation, and outpatient administration.

[Learn More](/research-and-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals/process-car-t-cell-therapy "The Process of CAR-T Cell Therapy")



 



## The Landscape

This page details the current landscape of treatment options for patients with haematologic malignancies, outlining key details about CAR-T cell therapy and standards of care such as stem cell transplant and cycling chemotherapy.

[Learn More](/research-and-development/technology-platforms/cell-therapy/car-t-cell-therapy-and-beyond/car-t-healthcare-professionals/treatment-landscape-haematologic-malignancies "The Treatment Landscape of Haematologic Malignancies")



 



## The Pioneers

This page outlines the Novartis CAR-T legacy, explaining the history of CAR-T cell therapy and future areas for exploration.

[Learn More](#)